Verrica Pharmaceuticals (VRCA) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.
- Verrica Pharmaceuticals' Enterprise Value rose 826.09% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.1 million, marking a year-over-year increase of 826.09%. This contributed to the annual value of -$46.3 million for FY2024, which is 3338.46% up from last year.
- Per Verrica Pharmaceuticals' latest filing, its Enterprise Value stood at -$21.1 million for Q3 2025, which was up 826.09% from -$15.4 million recorded in Q2 2025.
- Over the past 5 years, Verrica Pharmaceuticals' Enterprise Value peaked at -$15.4 million during Q2 2025, and registered a low of -$84.3 million during Q3 2023.
- Its 5-year average for Enterprise Value is -$39.6 million, with a median of -$34.3 million in 2022.
- Per our database at Business Quant, Verrica Pharmaceuticals' Enterprise Value plummeted by 15962.49% in 2023 and then skyrocketed by 7271.91% in 2024.
- Quarter analysis of 5 years shows Verrica Pharmaceuticals' Enterprise Value stood at -$15.8 million in 2021, then tumbled by 117.58% to -$34.3 million in 2022, then crashed by 102.92% to -$69.5 million in 2023, then skyrocketed by 33.38% to -$46.3 million in 2024, then soared by 54.46% to -$21.1 million in 2025.
- Its last three reported values are -$21.1 million in Q3 2025, -$15.4 million for Q2 2025, and -$29.6 million during Q1 2025.